Wednesday, February 8, 2023
Feb. 8, 2023

Linkedin Pinterest

Business

Business BriefsClark County BusinessColumnistsTransactionsWorking in Clark County

‘I feel duped’: Inside the fast-food industry’s push to dismantle a new California labor law

February 5, 2023, 6:02am Business

Susan Bushnell was in a hurry when a man, clipboard in hand, approached her outside a Walmart Supercenter in Vista, California, one afternoon last September. Read story

California grows more than 80% of the world???s almonds.

Environmental group urges California to limit the growing of almonds and alfalfa

California grows more than 80% of the world???s almonds.

February 5, 2023, 6:02am Business

As drought and climate change continue to wreak havoc on California’s water supply, an environmental advocacy group is calling on the state to limit the cultivation of thirsty crops like almonds and alfalfa, saying the agriculture industry is guzzling most of the state’s supplies at the expense of residents. Read story

Replacing U.S. coal plants with solar and wind is cheaper than running them

February 5, 2023, 6:02am Business

Replacing coal power plants across the United States with renewable energy projects would reduce carbon emissions and require less water. Read story

Most wealthy countries provide workers with paid time off when they become parents, fall ill or need to care for loved ones, however the U.S. doesn't offer one secured by the government.

After a brief pandemic reprieve, rural workers return to life without paid leave

Most wealthy countries provide workers with paid time off when they become parents, fall ill or need to care for loved ones, however the U.S. doesn't offer one secured by the government.

February 5, 2023, 6:00am Business

When Ruby B. Sutton found out she was pregnant in late 2021, it was hard to envision how her full-time job would fit with having a newborn at home. She faced a three-hour round-trip commute to the mine site where she worked as an environmental engineer, 12-plus-hour workdays, expensive child… Read story

Noncompete agreements cost Seattle-area man a new job, lawsuit says

February 5, 2023, 6:00am Business

Last March, Ian Morgan thought he was moving up in the world. Read story

Jeff Kurkewich, senior scientist on the genomic team at Delfi Diagnostics, works to extract DNA from tumor samples in Development Lab 1 to improve the assay. Delfi uses machine learning (artificial intelligence) algorithms to analyze blood samples and determine whether patients have cancer.

Researchers say AI could help reduce disparities, improve access in health care

Jeff Kurkewich, senior scientist on the genomic team at Delfi Diagnostics, works to extract DNA from tumor samples in Development Lab 1 to improve the assay. Delfi uses machine learning (artificial intelligence) algorithms to analyze blood samples and determine whether patients have cancer.

February 5, 2023, 5:59am Business

Cervical cancer, like many illnesses, is treatable if it’s caught early, but each year millions of women miss out on getting routine Pap smear screening for the disease, which kills a disproportionate number of Black women. Read story

Clark County health worker report

February 5, 2023, 5:56am Clark County Business

The Nursing Assistant Program and Mindy R. Garcia agreed to an order to reinstate her certified nursing assistant license with conditions. Garcia must comply with a substance use monitoring program. The Nursing Assistant Program summarily suspended the certified nursing assistant license of Blake Matthew Huegel, pending further disciplinary action. The… Read story

FILE - This Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. Leqembi, the first drug to show that it slows Alzheimer's, was approved by the U.S. Food and Drug Administration in early January 2023, but treatment for most patients is still several months away. Two big factors behind the slow debut, according to experts, are scant insurance coverage and a long setup time needed by many health systems.

New Alzheimer’s drug is having a slow debut in U.S.

FILE - This Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. Leqembi, the first drug to show that it slows Alzheimer's, was approved by the U.S. Food and Drug Administration in early January 2023, but treatment for most patients is still several months away. Two big factors behind the slow debut, according to experts, are scant insurance coverage and a long setup time needed by many health systems.

February 4, 2023, 7:28pm Business

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Read story